Market Cap
7117078016.00
HALO
Halozyme Therapeutics, Inc.
Exchange: nyse
Multiples
- P/E: 18.52
- P/BV: 15.72
- P/TBV: -21.37
Description:
HALO is the ticker symbol for Halozyme Therapeutics, Inc., a biotechnology company listed on the New York Stock Exchange (NYSE). The company specializes in the research, development, and commercialization of human enzyme therapies that address significant unmet medical needs across multiple therapeutic areas. Halozyme's proprietary enzyme rHuPH20, also known as Hyaluronidase, plays a crucial role in its innovative drug delivery systems, enabling more efficient administration of biologics and enhancing patient care. Through strategic partnerships with leading pharmaceutical companies, Halozyme aims to broaden the impact of its technology in oncology, ophthalmology, and other critical fields.
Data:
Yields:
Earnings Yield
0.636653217346
Return on Capital
0.583729405904
CAGR (net income)
34.54%
CAGR Length
3.75
Dividend Rate
